Maternal and Child Health Practice Questions

Q: As per WHO, low birth weight is defined as?

Birth weight less than 2.5 kg. ### Educational Explanation **1. Why Option A is Correct:** According to the World Health Organization (WHO), **Low Birth Weight (LBW)** is defined as a birth weight of **less than 2,500 grams (up to and including 2,499 g)**, regardless of gestational age. This measurement must be taken within the first hour of life, before significant postnatal weight loss occurs. This threshold is used globally because infants weighing less than 2.5 kg are at a significantly higher risk of neonatal mortality and long-term developmental morbidities. **2. Why the Other Options are Incorrect:** * **Option B:** A birth weight less than the **10th percentile** for a specific gestational age defines **Small for Gestational Age (SGA)**. While many LBW infants are SGA, the two terms are not synonymous; a premature baby may be "Appropriate for Gestational Age" but still be LBW. * **Options C & D:** These refer to **Preterm Birth**, which is defined by gestational age (less than 37 completed weeks). While prematurity is a leading cause of LBW, the definition of LBW itself is strictly based on weight, not the duration of pregnancy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Very Low Birth Weight (VLBW):** Weight less than **1,500 g**. * **Extremely Low Birth Weight (ELBW):** Weight less than **1,000 g**. * **Kangaroo Mother Care (KMC):** The gold standard intervention for stable LBW infants, involving continuous skin-to-skin contact and exclusive breastfeeding. * **Epidemiology:** India has one of the highest burdens of LBW globally; the primary maternal risk factors include poor nutritional status (low BMI), anemia, and young age at pregnancy.

Q: Single pill of MALA-D contains which of the following components?

L-norgestrel 0.15 mg and Ethinylestradiol (EE) 0.03 mg. **Explanation:** Mala-D and Mala-N are the standard Combined Oral Contraceptive Pills (COCPs) provided under the National Family Planning Programme in India. The correct composition of a single active pill is **0.15 mg of Levonorgestrel** (progestogen) and **0.03 mg (30 mcg) of Ethinylestradiol** (estrogen). 1. **Why Option A is correct:** This dosage represents a "low-dose" second-generation COCP. Levonorgestrel (L-norgestrel) is the active levorotatory isomer used in clinical practice. The 30 mcg dose of Ethinylestradiol is sufficient to inhibit ovulation by suppressing FSH/LH while minimizing estrogenic side effects like nausea and thromboembolism. 2. **Why Options B & D are incorrect:** These options swap the dosages. In COCPs, the progestogen component is always present in a higher numerical dose (milligrams) compared to the potent estrogen component (micrograms). 0.15 mg of EE would be a dangerously high dose. 3. **Why Option C is incorrect:** D-norgestrel (dextrorotatory) is pharmacologically inactive. Only the L-isomer (Levonorgestrel) binds to progesterone receptors to exert contraceptive effects. **High-Yield Clinical Pearls for NEET-PG:** * **Mala-D vs. Mala-N:** Both have the same hormonal composition. The only difference is that **Mala-D** (D = Desired) is a paid brand (nominal cost), while **Mala-N** (N = National/Nishulk) is distributed free of cost at government centers. * **Packet Composition:** Each cycle pack contains **28 pills**: 21 white hormonal pills and 7 brown non-hormonal pills (containing **60 mg Ferrous Fumarate**) to maintain the habit of daily pill-taking and prevent anemia. * **Mechanism of Action:** Primarily prevents ovulation by suppressing the LH surge; secondarily thickens cervical mucus and causes endometrial atrophy. * **Failure Rate:** 0.3 per 100 woman-years with perfect use (Pearl Index).

Q: When was the RCH programme launched?

1997. **Explanation:** The **Reproductive and Child Health (RCH) Programme Phase I** was officially launched by the Government of India on **October 15, 1997**. This program marked a paradigm shift in India's public health strategy, moving away from target-based population control toward a client-centered, holistic approach. It integrated several existing programs, including the Child Survival and Safe Motherhood (CSSM) program and Family Planning services, into a single composite package. **Analysis of Options:** * **1997 (Correct):** The RCH Phase I was launched in 1997 following the recommendations of the 1994 International Conference on Population and Development (ICPD) in Cairo. * **1993:** This period was the peak of the **CSSM (Child Survival and Safe Motherhood)** program, which was launched in 1992. * **1995:** This year is significant for the launch of the **Pulse Polio Immunization (PPI)** program in India, but not RCH. * **1999:** This was during the implementation phase of RCH-I; however, the subsequent major milestone, **RCH Phase II**, was not launched until April 2005 (alongside the NRHM). **High-Yield Clinical Pearls for NEET-PG:** * **RCH Phase I (1997):** Focused on "Essential Obstetric Care," "Emergency Obstetric Care," and "Referral Services." * **RCH Phase II (2005):** Shifted focus to **Outcome-based monitoring** and introduced the concept of **Janani Suraksha Yojana (JSY)**. * **Components of RCH:** Includes Maternal Health, Child Health, Family Planning, and Adolescent Health (ARSH), along with the management of RTIs/STIs. * **Current Strategy:** The RCH program has now evolved into the **RMNCH+A** (Reproductive, Maternal, Newborn, Child, and Adolescent Health) strategy, launched in **2013**, emphasizing the "Continuum of Care."

Q: What defines an eligible couple?

A couple where the wife is between 15 and 45 years of age.. ### Explanation **1. Why the Correct Answer is Right:** In Community Medicine, an **Eligible Couple** refers to a currently married couple where the wife is in the reproductive age group, traditionally defined as **15 to 45 years**. These couples are considered "eligible" because they are at risk of conception and are the primary target group for family planning and maternal health interventions. In some contexts, the upper age limit is extended to 49, but 15–45 remains the standard definition for most national health programs and demographic surveys in India. **2. Why the Other Options are Incorrect:** * **Option A & B:** The number of children (living or deceased) does not define an "eligible couple." Instead, a couple with two or more living children is specifically termed a **"Target Couple."** Target couples are a priority subgroup of eligible couples prioritized for permanent sterilization methods. * **Option D:** Willingness to undergo sterilization is a behavioral intent, not a demographic definition. While eligible couples are the candidates for sterilization, the definition is based on biological reproductive potential and marital status. **3. NEET-PG High-Yield Pearls:** * **Eligible Couple Register:** Maintained by the ANM at the Sub-center level; it is updated annually and serves as the basic document for family planning work. * **Target Couple:** A couple with 2–3 living children who are actively encouraged to adopt permanent or long-term limiting methods. * **Eligible Couple per 1000:** In India, there are approximately **150–180 eligible couples per 1000 population**. * **Couple Protection Rate (CPR):** The percentage of eligible couples effectively protected against childbirth by one or the other approved methods of family planning.

Q: What is the name of the newer contraceptive program introduced in Family Planning?

Antara. **Explanation:** The correct answer is **Antara**. Under the revamped National Family Planning Program, the Government of India introduced two newer contraceptives to expand the "basket of choice": **Antara** and **Chhaya**. * **Antara:** This is an **Injectable Contraceptive (DMPA - Medroxyprogesterone Acetate)**. It is administered intramuscularly every 3 months (90 days). It works primarily by suppressing ovulation and thickening cervical mucus. * **Chhaya:** Introduced alongside Antara, this is a non-hormonal, non-steroidal once-a-week oral contraceptive pill (Centchroman). **Analysis of Incorrect Options:** * **Parivahana:** This is not a contraceptive program. It likely refers to transport-related schemes (e.g., *Mission Parivar Vikas* is the actual family planning mission, but "Parivahana" is a distractor). * **Prerana:** This is a strategy by the Jansankhya Sthirata Kosh (JSK) aimed at delaying marriage and spacing births among BPL families, but it is not the name of a specific contraceptive method. * **Indradanush (Mission Indradanush):** This is India’s flagship **immunization program** aimed at increasing full immunization coverage for children and pregnant women; it is unrelated to contraception. **High-Yield Clinical Pearls for NEET-PG:** * **Antara Dosage:** 150 mg IM every 3 months. * **Injection Site:** Deep intramuscular (Gluteal or Deltoid). Do not massage the site after injection. * **Common Side Effect:** Menstrual irregularities (amenorrhea or breakthrough bleeding) is the most common reason for discontinuation. * **Mission Parivar Vikas:** Launched in 146 high-fertility districts to accelerate access to these newer contraceptives.

Q: According to the WHO Medical Eligibility Criteria for Contraceptive Use, what does Category 4 signify?

Absolute contraindications. The WHO Medical Eligibility Criteria (MEC) is a standardized framework used to guide clinicians on the safety of various contraceptive methods for individuals with specific medical conditions. ### **Explanation of the Correct Answer** **Category 4** signifies an **absolute contraindication**. In this category, the use of the contraceptive method represents an **unacceptable health risk** to the patient. The risks far outweigh any potential benefits, and the method must not be used under any circumstances (e.g., using Combined Oral Contraceptives in a woman with a history of breast cancer or current deep vein thrombosis). ### **Analysis of Incorrect Options** * **Option A (No restriction):** This describes **Category 1**, where the method can be used without any limitations for the specific condition. * **Option C (Relative contraindications):** This encompasses **Category 2** (Advantages generally outweigh risks; method can be used) and **Category 3** (Risks generally outweigh advantages; method should not be used unless other safer methods are unavailable or unacceptable). * **Option D (Special conditions):** While the WHO MEC covers conditions like HIV, it classifies them into Categories 1-4 based on the specific contraceptive method and clinical status (e.g., drug interactions with ART). ### **NEET-PG High-Yield Pearls** * **Category 1:** Use the method in any circumstances. * **Category 2:** Generally use the method. * **Category 3:** Use of method not usually recommended unless other more appropriate methods are not available or not acceptable. * **Category 4:** Method not to be used. * **Common Category 4 Examples for COCs:** Age ≥35 and smoking ≥15 cigarettes/day, Migraine with aura, Hypertension (≥160/100), and Ischemic heart disease.

Q: All of the following are intranatal causes of perinatal mortality except?

Antepartum hemorrhage. ### Explanation The **Perinatal Mortality Rate (PMR)** includes late fetal deaths (stillbirths after 28 weeks of gestation) and early neonatal deaths (deaths within the first 7 days of life). Causes are categorized based on the timing of the insult: **Antenatal** (before labor), **Intranatal** (during labor/delivery), and **Postnatal** (after birth). **Why Antepartum Hemorrhage (APH) is the correct answer:** Antepartum hemorrhage (bleeding from the genital tract after 28 weeks but *before* the onset of labor) is strictly an **Antenatal cause**. While it significantly contributes to perinatal mortality by causing fetal hypoxia or preterm birth, the insult occurs prior to the intranatal period. **Analysis of Incorrect Options (Intranatal Causes):** * **Birth Injuries:** These occur due to mechanical trauma during the process of delivery (e.g., shoulder dystocia, forceps application), making it a classic intranatal cause. * **Birth Asphyxia:** This refers to the failure to initiate or sustain breathing at birth, usually resulting from hypoxia during labor (e.g., cord prolapse or placental insufficiency during contractions). It is a leading intranatal cause of death. * **Obstructed Labor:** This is a purely intranatal complication where the fetus cannot descend through the birth canal despite good uterine contractions. It leads to fetal distress, rupture of the uterus, or birth asphyxia. **High-Yield Pearls for NEET-PG:** * **Definition of Perinatal Period:** Starts at 28 weeks of gestation and ends 7 days after birth. * **Most Common Cause of PMR in India:** Low Birth Weight (LBW) and Prematurity. * **Intranatal Period:** Defined from the onset of labor until the delivery of the placenta. * **PMR Formula:** (Late fetal deaths + Early neonatal deaths) / (Total Live births + Stillbirths) × 1000.

Q: In GOBI, what does the letter 'O' stand for?

Oral rehydration. **Explanation:** The acronym **GOBI** was introduced by UNICEF in 1982 as a part of the "Child Survival Revolution." It represents a selective package of low-cost, high-impact primary health care interventions designed to reduce infant and child mortality in developing nations. * **Why 'Oral Rehydration' is correct:** The 'O' stands for **Oral Rehydration Therapy (ORT)**. Diarrheal diseases are a leading cause of death in children under five, primarily due to dehydration. ORT (using ORS solution) is a simple, cost-effective intervention that prevents and treats dehydration, significantly reducing child mortality. **Analysis of Incorrect Options:** * **A. Oral hygiene:** While important for general health, it is not a life-saving emergency intervention prioritized in the GOBI framework for reducing under-five mortality. * **C. Oral drugs:** This is too vague. While specific drugs (like antibiotics for pneumonia) are vital, the GOBI strategy focuses on specific, standardized interventions rather than general pharmacotherapy. **High-Yield Facts for NEET-PG:** * **GOBI components:** * **G:** Growth Monitoring (using Road to Health charts to detect malnutrition early). * **O:** Oral Rehydration. * **B:** Breastfeeding (exclusive breastfeeding for the first 6 months). * **I:** Immunization (against the six vaccine-preventable diseases). * **GOBI-FFF:** Later, three more elements were added to form GOBI-FFF: **F**emale Education, **F**amily Spacing, and **F**ood Supplementation. * **Concept:** This represents the "Selective Primary Health Care" approach, focusing on specific medical interventions rather than the "Universal" approach of the Alma-Ata Declaration.

Q: "Baby-friendly hospital initiative" (BFHI), created and promoted by WHO and which other organization?

UNICEF. **Explanation:** The **Baby-Friendly Hospital Initiative (BFHI)** was launched in **1991** as a joint global effort by the **World Health Organization (WHO)** and the **United Nations Children's Fund (UNICEF)**. The initiative was established to implement practices that protect, promote, and support breastfeeding, based on the **"Ten Steps to Successful Breastfeeding."** **Why UNICEF is correct:** UNICEF is the primary UN agency dedicated to the welfare and health of children. Since BFHI focuses on improving neonatal outcomes through optimal feeding practices, UNICEF partnered with WHO to mobilize health facilities worldwide to become "Baby-Friendly." **Why other options are incorrect:** * **USAID (B):** An independent agency of the US government focused on international development; while they fund health programs, they did not co-create the BFHI. * **UNDP (C):** Focuses on poverty eradication and sustainable economic growth rather than specific clinical maternal-child health protocols. * **FAO (D):** The Food and Agriculture Organization focuses on global hunger and food security, not hospital-based clinical practices. **High-Yield Clinical Pearls for NEET-PG:** * **The Ten Steps:** These are the core of BFHI. Key steps include initiating breastfeeding within **30 minutes** of birth, practicing **rooming-in** (keeping mothers and infants together 24 hours a day), and giving no food or drink other than breast milk unless medically indicated. * **Innocenti Declaration (1990):** The BFHI was a direct outcome of this declaration, which set global goals for breastfeeding. * **Prohibition:** Baby-friendly hospitals are prohibited from accepting free or low-cost breast milk substitutes (formula) or promoting pacifiers/artificial nipples.

Q: All of the following are components of the Child Survival and Safe Motherhood Programme except?

Medical termination of pregnancy. The **Child Survival and Safe Motherhood (CSSM) Programme**, launched in **1992**, was a major milestone in Indian public health, integrating child survival interventions with maternal health care. ### **Explanation of the Correct Answer** **Option A (Medical Termination of Pregnancy)** is the correct answer because it was **not** a formal component of the CSSM programme. While MTP is a crucial part of reproductive health services in India (governed by the MTP Act, 1971), the CSSM focused primarily on reducing maternal mortality through "Safe Motherhood" interventions and child mortality through immunization and disease control. MTP services were later integrated more comprehensively under the **RCH-I (Reproductive and Child Health)** phase in 1997. ### **Analysis of Incorrect Options** * **Option B (Advice on food, nutrition, and rest):** This was a core component of the "Safe Motherhood" package. It aimed to prevent maternal anemia and low birth weight. * **Option C (Detection and referral of high-risk pregnancies):** A primary objective of CSSM was to train health workers to identify complications (like eclampsia or obstructed labor) early and refer them to First Referral Units (FRUs). * **Option D (Birth spacing):** Promoting birth spacing was essential to improve both maternal recovery and child survival rates, making it a key pillar of the programme. ### **High-Yield Clinical Pearls for NEET-PG** * **Timeline:** CSSM (1992) → RCH Phase I (1997) → RCH Phase II (2005) → NRHM (2005) → RMNCH+A (2013). * **CSSM Components:** * **Child Survival:** Immunization, Vitamin A prophylaxis, ORT for Diarrhea, and ARI control. * **Safe Motherhood:** Antenatal care, Tetanus Toxoid immunization, Anemia control, Obstetric care, and Birth spacing. * **Target:** CSSM aimed to achieve an IMR of <60/1000 live births and an MMR of <200/100,000 live births.

Question 1

As per WHO, low birth weight is defined as?

Accepted Answer

Birth weight less than 2.5 kg

Answer

Birth weight less than 10th percentile

Answer

Gestational age less than 28 weeks

Answer

Gestational age less than 34 weeks

Question 2

Single pill of MALA-D contains which of the following components?

Accepted Answer

L-norgestrel 0.15 mg and Ethinylestradiol (EE) 0.03 mg

Answer

L-norgestrel 0.03 mg and Ethinylestradiol (EE) 0.15 mg

Answer

D-norgestrel 0.15 mg and Ethinylestradiol (EE) 0.03 mg

Answer

D-norgestrel 0.03 mg and Ethinylestradiol (EE) 0.15 mg

Question 3

When was the RCH programme launched?

Accepted Answer

1997

Answer

1993

Answer

1995

Answer

1999

Question 4

What defines an eligible couple?

Accepted Answer

A couple where the wife is between 15 and 45 years of age.

Answer

A couple with two living children.

Answer

A couple who has had two children, regardless of whether they are alive.

Answer

A couple willing to undergo sterilization.

Question 5

What is the name of the newer contraceptive program introduced in Family Planning?

Accepted Answer

Antara

Answer

Parivahana

Answer

Prerana

Answer

Indradanush

Question 6

According to the WHO Medical Eligibility Criteria for Contraceptive Use, what does Category 4 signify?

Accepted Answer

Absolute contraindications

Answer

No restriction to use

Answer

Relative contraindications

Answer

Contraception in special conditions, such as HIV

Question 7

All of the following are intranatal causes of perinatal mortality except?

Accepted Answer

Antepartum hemorrhage

Answer

Birth injuries

Answer

Birth asphyxia

Answer

Obstructed labor

Question 8

In GOBI, what does the letter 'O' stand for?

Accepted Answer

Oral rehydration

Answer

Oral hygiene

Answer

Oral drugs

Answer

None of the above

Question 9

"Baby-friendly hospital initiative" (BFHI), created and promoted by WHO and which other organization?

Accepted Answer

UNICEF

Answer

USAID

Answer

UNDP

Answer

FAO

Question 10

All of the following are components of the Child Survival and Safe Motherhood Programme except?

Accepted Answer

Medical termination of pregnancy

Answer

Advice of food, nutrition and rest

Answer

Detection and referral of high risk pregnancies

Answer

Birth spacing

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?